Androgen News and Research

RSS
FDA clears its IND for new immunotherapeutic for treating prostate cancer

FDA clears its IND for new immunotherapeutic for treating prostate cancer

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park receives more than $15 million in grants for cancer research

New oral androgen deprivation therapy increases risk of death in cardiovascular patients

New oral androgen deprivation therapy increases risk of death in cardiovascular patients

Study finds attractive therapeutic target for treatment of Kennedy's disease and prostrate cancer

Study finds attractive therapeutic target for treatment of Kennedy's disease and prostrate cancer

Estrogen exposure during fetal life increases autism risk

Estrogen exposure during fetal life increases autism risk

Researchers identify key to controlling growth and progression of prostate cancer

Researchers identify key to controlling growth and progression of prostate cancer

Study reveals how aggressive prostate cancer metastasizes by evading the immune system

Study reveals how aggressive prostate cancer metastasizes by evading the immune system

Could hormone therapy for prostate cancer increase the risk of Alzheimer’s disease?

Could hormone therapy for prostate cancer increase the risk of Alzheimer’s disease?

Study finds new cancer driver which is fast, furious and loud

Study finds new cancer driver which is fast, furious and loud

Novel combination therapy shown to be safe and effective for prostate cancer patients

Novel combination therapy shown to be safe and effective for prostate cancer patients

Biomarker correlates with prostate cancer aggressiveness and predicts metastasis to bone

Biomarker correlates with prostate cancer aggressiveness and predicts metastasis to bone

International clinical study of new drug to treat advanced prostate cancers yields promising results

International clinical study of new drug to treat advanced prostate cancers yields promising results

Oral androgen receptor inhibitor improves outcomes for men with mHSPC

Oral androgen receptor inhibitor improves outcomes for men with mHSPC

Inhibition of protein may prevent spread of castration-resistant prostate cancer

Inhibition of protein may prevent spread of castration-resistant prostate cancer

Genomics study reveals five genes linked to treatment resistance in prostate cancer

Genomics study reveals five genes linked to treatment resistance in prostate cancer

New method could lead to more personalized treatment of advanced prostate cancer

New method could lead to more personalized treatment of advanced prostate cancer

Half of all women with PCOS share a rare gene variant

Half of all women with PCOS share a rare gene variant

Ambiguous genitalia in newborns may be more common than previously thought

Ambiguous genitalia in newborns may be more common than previously thought

Male contraceptive pill shown to be safe and tolerable in phase I trial

Male contraceptive pill shown to be safe and tolerable in phase I trial

European Parliament's report calls on EU to develop policies to regulate endocrine-disrupting chemicals

European Parliament's report calls on EU to develop policies to regulate endocrine-disrupting chemicals

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.